DD210266A5 - Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten - Google Patents

Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten Download PDF

Info

Publication number
DD210266A5
DD210266A5 DD83251330A DD25133083A DD210266A5 DD 210266 A5 DD210266 A5 DD 210266A5 DD 83251330 A DD83251330 A DD 83251330A DD 25133083 A DD25133083 A DD 25133083A DD 210266 A5 DD210266 A5 DD 210266A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
formula
hydrogen
compounds
salts
Prior art date
Application number
DD83251330A
Other languages
German (de)
English (en)
Inventor
Lincoln H Werner
Neville Ford
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD210266A5 publication Critical patent/DD210266A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/36One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD83251330A 1982-05-28 1983-05-27 Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten DD210266A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38304982A 1982-05-28 1982-05-28

Publications (1)

Publication Number Publication Date
DD210266A5 true DD210266A5 (de) 1984-06-06

Family

ID=23511486

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83251330A DD210266A5 (de) 1982-05-28 1983-05-27 Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten

Country Status (16)

Country Link
EP (1) EP0096006A3 (fr)
JP (1) JPS5931753A (fr)
KR (1) KR840004729A (fr)
AU (1) AU559970B2 (fr)
CA (1) CA1215711A (fr)
DD (1) DD210266A5 (fr)
DK (1) DK238083A (fr)
ES (4) ES8604887A1 (fr)
FI (1) FI831863A7 (fr)
GR (1) GR79228B (fr)
IL (1) IL68794A0 (fr)
NO (1) NO158343C (fr)
NZ (1) NZ204383A (fr)
PH (1) PH20374A (fr)
PT (1) PT76772B (fr)
ZA (1) ZA833861B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689111D1 (de) * 1985-12-13 1993-11-04 Ciba Geigy Verbessertes verfahren zur herstellung von glycidylverbindungen.
SE9802208D0 (sv) 1998-06-22 1998-06-22 Astra Pharma Inc Novel compounds
IL152528A0 (en) * 2000-07-13 2003-05-29 Lilly Co Eli Beta3 adrenergic agonists
EP1608373A4 (fr) * 2003-03-19 2010-09-29 Exelixis Inc Modulateurs de tie-2 et procedes d`utilisation
FR2935141B1 (fr) * 2008-08-21 2010-10-08 Sanofi Aventis Procede de preparation de l'ester ethylique de l'acide 4-[trans-4-[(phenylmethyl)-amino]cyclohexyl]benzoique et de son sel hemifumarate

Also Published As

Publication number Publication date
ES8608492A1 (es) 1986-06-16
EP0096006A3 (fr) 1984-12-19
ES8604887A1 (es) 1986-02-16
FI831863L (fi) 1983-11-29
KR840004729A (ko) 1984-10-24
ES8607942A1 (es) 1986-06-01
DK238083D0 (da) 1983-05-27
EP0096006A2 (fr) 1983-12-07
FI831863A7 (fi) 1983-11-29
CA1215711A (fr) 1986-12-23
NO158343C (no) 1988-08-24
ZA833861B (en) 1984-02-29
ES522723A0 (es) 1986-02-16
AU1520183A (en) 1983-12-01
IL68794A0 (en) 1983-09-30
DK238083A (da) 1983-11-29
ES8607943A1 (es) 1986-06-01
GR79228B (fr) 1984-10-22
ES535963A0 (es) 1986-06-16
NO831901L (no) 1983-11-29
JPS5931753A (ja) 1984-02-20
PT76772A (en) 1983-06-01
AU559970B2 (en) 1987-03-26
FI831863A0 (fi) 1983-05-25
NZ204383A (en) 1985-12-13
NO158343B (no) 1988-05-16
PH20374A (en) 1986-12-08
PT76772B (en) 1986-03-27
ES535965A0 (es) 1986-06-01
ES535964A0 (es) 1986-06-01

Similar Documents

Publication Publication Date Title
EP0136658B1 (fr) -1-Benzyl-aminoalkyl-pyrrolidinones et leurs sels d'addition, procédé de préparation et médicaments les contenant
DE3631824A1 (de) Cycloalkano(1.2-b)indol-sulfonamide
EP0483580A2 (fr) 1-(2-Aryléthyl)-pyrrolidines
DE3430284A1 (de) Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung
DE19604920A1 (de) Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
DD149071A5 (de) Herstellung 2-substituierter trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
EP0185909B1 (fr) Composés de 5-alkyl-1-phényl-2-pipérazinoalkylpyrazolin-3-one ainsi que procédés et produits intermédiaires pour leur préparation et médicaments comprenant ces composés
DD271517A5 (de) Verfahren zur herstellung von neuen naphthylderivaten
DE3813531A1 (de) Neue 2-aminoalkyl-4-benzyl-1-(2h)-phthalazinon-derivate
EP0072960B1 (fr) Composés 1,5-diphénylpyrazolin-3-one, ainsi qu'un procédé et produits intermédiaires pour leur fabrication et médicaments contenant ces composés
CH678322A5 (fr)
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten
EP0065295A1 (fr) Dérivés de la tryptamine et de la thiényloxypropanolamine, procédé pour leur préparation, compositions pharmaceutiques les contenant et préparation de celles-ci
EP0002672A2 (fr) Pyrrolidines substituées, procédé pour leur préparation et médicaments les contenant
EP0491243B1 (fr) Composés alkylaminoalkylamines et -éthers ainsi que des procédés et composés intermédiaires pour leur préparation et médicaments contenant ces composés
JPH037280A (ja) 新規ベンゾチオピラニルアミン
EP1104419B1 (fr) Derives a substitution n d'azacycloheptane, preparation et utilisation desdits utilises
EP0037990A1 (fr) Phénylquinolizidines, compositions pharmaceutiques correspondantes, préparation d'ingrédients actifs et produits de départ correspondants
DD153691A5 (de) Verfahren zur herstellung von hexahydro-trans-4a,9b-1(h)pyridoindol-derivaten
DE3813416A1 (de) 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
EP0025501A1 (fr) Dérivés de N-aminoalkylindole et leurs sels; procédés pour leur préparation et médicaments contenant ces composés
DE2720968C2 (de) N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel
DE69310186T2 (de) 1,2-dihydro-2-oxo-3-aminochinoxalin derivate, ihre verwendung als heilmittel
EP0001585A1 (fr) Dérivés de pipérazino-pyrrolobenzodiazépine, leurs procédés de préparation et compositions pharmaceutiques les contenant
DD215540A5 (de) Verfahren zur herstellung von benzazepinderivaten